新光药业
(300519)
| 流通市值：18.63亿 | | | 总市值：26.13亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 421,525,513.68 | 311,836,015.14 | 290,631,157.54 | 306,321,596.05 |
| 交易性金融资产 | 350,000,000 | 400,000,000 | 400,000,000 | 370,000,000 |
| 应收票据及应收账款 | 7,422,763.85 | 10,420,140.26 | 13,036,320.47 | 10,831,408.99 |
| 应收账款 | 7,422,763.85 | 10,420,140.26 | 13,036,320.47 | 10,831,408.99 |
| 应收款项融资 | 727,538.32 | 688,648 | 702,383.22 | 274,738.7 |
| 预付款项 | 1,759,873.76 | 56,535.78 | 1,688,518.38 | 370,109.83 |
| 其他应收款合计 | 130,391.39 | 160,411.89 | 190,430.9 | 220,451.4 |
| 存货 | 26,092,534.47 | 43,268,576.42 | 60,455,474.58 | 61,596,098.12 |
| 其他流动资产 | 829,061.41 | 910,027.12 | 944,181 | 1,015,841.37 |
| 流动资产合计 | 808,487,676.88 | 767,340,354.61 | 767,648,466.09 | 750,630,244.46 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 15,851,941 | 21,500,353.25 | 21,514,953.28 | 21,677,474.2 |
| 固定资产 | 89,549,333.75 | 92,963,260.42 | 96,377,967.5 | 99,358,272.08 |
| 在建工程 | - | - | - | 419,822.06 |
| 无形资产 | 7,512,868.69 | 7,585,524.48 | 7,658,180.27 | 7,730,836.06 |
| 递延所得税资产 | - | 26,626.83 | 206,576.88 | 123,077.77 |
| 非流动资产合计 | 112,914,143.44 | 122,075,764.98 | 125,757,677.93 | 129,309,482.17 |
| 资产总计 | 921,401,820.32 | 889,416,119.59 | 893,406,144.02 | 879,939,726.63 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 35,304,853.07 | 28,580,457.61 | 46,870,306.5 | 51,359,739.65 |
| 应付账款 | 35,304,853.07 | 28,580,457.61 | 46,870,306.5 | 51,359,739.65 |
| 预收款项 | 52,662.85 | 70,217.14 | - | - |
| 合同负债 | 4,137,066.94 | 285,307.81 | 353,790.84 | 454,814.21 |
| 应付职工薪酬 | 601,459.75 | 3,568,509.7 | 764,575.92 | 738,597.52 |
| 应交税费 | 7,819,338.16 | 7,747,640.22 | 7,826,095.78 | 3,762,463.13 |
| 其他应付款合计 | 912,000 | 4,420,453.41 | 1,382,631.26 | 955,797.09 |
| 其他流动负债 | 537,818.7 | 37,090.01 | 45,992.81 | 59,125.85 |
| 流动负债合计 | 49,365,199.47 | 44,709,675.9 | 57,243,393.11 | 57,330,537.45 |
| 非流动负债: | | | | |
| 长期应付款 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 |
| 递延收益 | 5,213,638.36 | 5,532,815.77 | 5,851,993.15 | 5,588,770.56 |
| 递延所得税负债 | 28,129.64 | - | - | - |
| 非流动负债合计 | 7,604,154.46 | 7,895,202.23 | 8,214,379.61 | 7,951,157.02 |
| 负债合计 | 56,969,353.93 | 52,604,878.13 | 65,457,772.72 | 65,281,694.47 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 |
| 其他综合收益 | 3,251,292.91 | 3,374,043.32 | 3,386,453.34 | 3,524,596.13 |
| 盈余公积 | 122,307,827.59 | 122,307,827.59 | 116,924,680.74 | 116,924,680.74 |
| 未分配利润 | 417,584,311.37 | 389,840,336.03 | 386,348,202.7 | 372,919,720.77 |
| 归属于母公司股东权益合计 | 864,432,466.39 | 836,811,241.46 | 827,948,371.3 | 814,658,032.16 |
| 股东权益合计 | 864,432,466.39 | 836,811,241.46 | 827,948,371.3 | 814,658,032.16 |
| 负债和股东权益合计 | 921,401,820.32 | 889,416,119.59 | 893,406,144.02 | 879,939,726.63 |
| 公告日期 | 2026-04-21 | 2026-04-21 | 2025-10-28 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |